Global Alzheimer's Disease Drug Market Growth 2022-2028
As the global economy mends, the 2021 growth of Alzheimer's Disease Drug will have significant change from previous year. According to our latest study, the global Alzheimer's Disease Drug market size is USD million in 2022 from USD 3539.3 million in 2021, with a change of % between 2021 and 2022. The global Alzheimer's Disease Drug market size will reach USD 3943.3 million in 2028, growing at a CAGR of 1.6% over the analysis period.
The United States Alzheimer's Disease Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alzheimer's Disease Drug market, reaching US$ million by the year 2028. As for the Europe Alzheimer's Disease Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Alzheimer's Disease Drug players cover Allergan, Eisai, Novartis, and Daiichi Sankyo, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Alzheimer's Disease Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Donepezil
Memantine
Rivastigmine
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Early to Moderate Stages
Moderate to Severe Stages
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alzheimer's Disease Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alzheimer's Disease Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alzheimer's Disease Drug by Country/Region, 2017, 2022 & 2028
2.2 Alzheimer's Disease Drug Segment by Type
2.2.1 Donepezil
2.2.2 Memantine
2.2.3 Rivastigmine
2.2.4 Others
2.3 Alzheimer's Disease Drug Sales by Type
2.3.1 Global Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Alzheimer's Disease Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Alzheimer's Disease Drug Sale Price by Type (2017-2022)
2.4 Alzheimer's Disease Drug Segment by Application
2.4.1 Early to Moderate Stages
2.4.2 Moderate to Severe Stages
2.5 Alzheimer's Disease Drug Sales by Application
2.5.1 Global Alzheimer's Disease Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Alzheimer's Disease Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alzheimer's Disease Drug Sale Price by Application (2017-2022)
3 Global Alzheimer's Disease Drug by Company
3.1 Global Alzheimer's Disease Drug Breakdown Data by Company
3.1.1 Global Alzheimer's Disease Drug Annual Sales by Company (2020-2022)
3.1.2 Global Alzheimer's Disease Drug Sales Market Share by Company (2020-2022)
3.2 Global Alzheimer's Disease Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Alzheimer's Disease Drug Revenue by Company (2020-2022)
3.2.2 Global Alzheimer's Disease Drug Revenue Market Share by Company (2020-2022)
3.3 Global Alzheimer's Disease Drug Sale Price by Company
3.4 Key Manufacturers Alzheimer's Disease Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alzheimer's Disease Drug Product Location Distribution
3.4.2 Players Alzheimer's Disease Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Alzheimer's Disease Drug by Geographic Region
4.1 World Historic Alzheimer's Disease Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Alzheimer's Disease Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alzheimer's Disease Drug Annual Revenue by Geographic Region
4.2 World Historic Alzheimer's Disease Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Alzheimer's Disease Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alzheimer's Disease Drug Annual Revenue by Country/Region
4.3 Americas Alzheimer's Disease Drug Sales Growth
4.4 APAC Alzheimer's Disease Drug Sales Growth
4.5 Europe Alzheimer's Disease Drug Sales Growth
4.6 Middle East & Africa Alzheimer's Disease Drug Sales Growth
5 Americas
5.1 Americas Alzheimer's Disease Drug Sales by Country
5.1.1 Americas Alzheimer's Disease Drug Sales by Country (2017-2022)
5.1.2 Americas Alzheimer's Disease Drug Revenue by Country (2017-2022)
5.2 Americas Alzheimer's Disease Drug Sales by Type
5.3 Americas Alzheimer's Disease Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alzheimer's Disease Drug Sales by Region
6.1.1 APAC Alzheimer's Disease Drug Sales by Region (2017-2022)
6.1.2 APAC Alzheimer's Disease Drug Revenue by Region (2017-2022)
6.2 APAC Alzheimer's Disease Drug Sales by Type
6.3 APAC Alzheimer's Disease Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alzheimer's Disease Drug by Country
7.1.1 Europe Alzheimer's Disease Drug Sales by Country (2017-2022)
7.1.2 Europe Alzheimer's Disease Drug Revenue by Country (2017-2022)
7.2 Europe Alzheimer's Disease Drug Sales by Type
7.3 Europe Alzheimer's Disease Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alzheimer's Disease Drug by Country
8.1.1 Middle East & Africa Alzheimer's Disease Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alzheimer's Disease Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Alzheimer's Disease Drug Sales by Type
8.3 Middle East & Africa Alzheimer's Disease Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug
10.3 Manufacturing Process Analysis of Alzheimer's Disease Drug
10.4 Industry Chain Structure of Alzheimer's Disease Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alzheimer's Disease Drug Distributors
11.3 Alzheimer's Disease Drug Customer
12 World Forecast Review for Alzheimer's Disease Drug by Geographic Region
12.1 Global Alzheimer's Disease Drug Market Size Forecast by Region
12.1.1 Global Alzheimer's Disease Drug Forecast by Region (2023-2028)
12.1.2 Global Alzheimer's Disease Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alzheimer's Disease Drug Forecast by Type
12.7 Global Alzheimer's Disease Drug Forecast by Application
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Alzheimer's Disease Drug Product Offered
13.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Alzheimer's Disease Drug Product Offered
13.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Alzheimer's Disease Drug Product Offered
13.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Daiichi Sankyo
13.4.1 Daiichi Sankyo Company Information
13.4.2 Daiichi Sankyo Alzheimer's Disease Drug Product Offered
13.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Daiichi Sankyo Main Business Overview
13.4.5 Daiichi Sankyo Latest Developments
13.5 Merz Pharma
13.5.1 Merz Pharma Company Information
13.5.2 Merz Pharma Alzheimer's Disease Drug Product Offered
13.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merz Pharma Main Business Overview
13.5.5 Merz Pharma Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Alzheimer's Disease Drug Product Offered
13.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Alzheimer's Disease Drug Product Offered
13.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Lundbeck
13.8.1 Lundbeck Company Information
13.8.2 Lundbeck Alzheimer's Disease Drug Product Offered
13.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lundbeck Main Business Overview
13.8.5 Lundbeck Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Alzheimer's Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alzheimer's Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Donepezil
Table 4. Major Players of Memantine
Table 5. Major Players of Rivastigmine
Table 6. Major Players of Others
Table 7. Global Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
Table 8. Global Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
Table 9. Global Alzheimer's Disease Drug Revenue by Type (2017-2022) & ($ million)
Table 10. Global Alzheimer's Disease Drug Revenue Market Share by Type (2017-2022)
Table 11. Global Alzheimer's Disease Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
Table 13. Global Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
Table 14. Global Alzheimer's Disease Drug Revenue by Application (2017-2022)
Table 15. Global Alzheimer's Disease Drug Revenue Market Share by Application (2017-2022)
Table 16. Global Alzheimer's Disease Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Alzheimer's Disease Drug Sales by Company (2020-2022) & (M Units)
Table 18. Global Alzheimer's Disease Drug Sales Market Share by Company (2020-2022)
Table 19. Global Alzheimer's Disease Drug Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Alzheimer's Disease Drug Revenue Market Share by Company (2020-2022)
Table 21. Global Alzheimer's Disease Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Alzheimer's Disease Drug Producing Area Distribution and Sales Area
Table 23. Players Alzheimer's Disease Drug Products Offered
Table 24. Alzheimer's Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Alzheimer's Disease Drug Sales by Geographic Region (2017-2022) & (M Units)
Table 28. Global Alzheimer's Disease Drug Sales Market Share Geographic Region (2017-2022)
Table 29. Global Alzheimer's Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Alzheimer's Disease Drug Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Alzheimer's Disease Drug Sales by Country/Region (2017-2022) & (M Units)
Table 32. Global Alzheimer's Disease Drug Sales Market Share by Country/Region (2017-2022)
Table 33. Global Alzheimer's Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Alzheimer's Disease Drug Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)
Table 36. Americas Alzheimer's Disease Drug Sales Market Share by Country (2017-2022)
Table 37. Americas Alzheimer's Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Alzheimer's Disease Drug Revenue Market Share by Country (2017-2022)
Table 39. Americas Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
Table 40. Americas Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
Table 41. Americas Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
Table 42. Americas Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
Table 43. APAC Alzheimer's Disease Drug Sales by Region (2017-2022) & (M Units)
Table 44. APAC Alzheimer's Disease Drug Sales Market Share by Region (2017-2022)
Table 45. APAC Alzheimer's Disease Drug Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Alzheimer's Disease Drug Revenue Market Share by Region (2017-2022)
Table 47. APAC Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
Table 48. APAC Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
Table 49. APAC Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
Table 50. APAC Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
Table 51. Europe Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)
Table 52. Europe Alzheimer's Disease Drug Sales Market Share by Country (2017-2022)
Table 53. Europe Alzheimer's Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Alzheimer's Disease Drug Revenue Market Share by Country (2017-2022)
Table 55. Europe Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
Table 56. Europe Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
Table 57. Europe Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
Table 58. Europe Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Alzheimer's Disease Drug Sales by Country (2017-2022) & (M Units)
Table 60. Middle East & Africa Alzheimer's Disease Drug Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Alzheimer's Disease Drug Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Alzheimer's Disease Drug Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Alzheimer's Disease Drug Sales by Type (2017-2022) & (M Units)
Table 64. Middle East & Africa Alzheimer's Disease Drug Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Alzheimer's Disease Drug Sales by Application (2017-2022) & (M Units)
Table 66. Middle East & Africa Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Alzheimer's Disease Drug
Table 68. Key Market Challenges & Risks of Alzheimer's Disease Drug
Table 69. Key Industry Trends of Alzheimer's Disease Drug
Table 70. Alzheimer's Disease Drug Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Alzheimer's Disease Drug Distributors List
Table 73. Alzheimer's Disease Drug Customer List
Table 74. Global Alzheimer's Disease Drug Sales Forecast by Region (2023-2028) & (M Units)
Table 75. Global Alzheimer's Disease Drug Sales Market Forecast by Region
Table 76. Global Alzheimer's Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Alzheimer's Disease Drug Sales Forecast by Country (2023-2028) & (M Units)
Table 79. Americas Alzheimer's Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Alzheimer's Disease Drug Sales Forecast by Region (2023-2028) & (M Units)
Table 81. APAC Alzheimer's Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Alzheimer's Disease Drug Sales Forecast by Country (2023-2028) & (M Units)
Table 83. Europe Alzheimer's Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Alzheimer's Disease Drug Sales Forecast by Country (2023-2028) & (M Units)
Table 85. Middle East & Africa Alzheimer's Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Alzheimer's Disease Drug Sales Forecast by Type (2023-2028) & (M Units)
Table 87. Global Alzheimer's Disease Drug Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Alzheimer's Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Alzheimer's Disease Drug Sales Forecast by Application (2023-2028) & (M Units)
Table 91. Global Alzheimer's Disease Drug Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Alzheimer's Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Alzheimer's Disease Drug Revenue Market Share Forecast by Application (2023-2028)
Table 94. Allergan Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 95. Allergan Alzheimer's Disease Drug Product Offered
Table 96. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Allergan Main Business
Table 98. Allergan Latest Developments
Table 99. Eisai Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 100. Eisai Alzheimer's Disease Drug Product Offered
Table 101. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Eisai Main Business
Table 103. Eisai Latest Developments
Table 104. Novartis Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 105. Novartis Alzheimer's Disease Drug Product Offered
Table 106. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Novartis Main Business
Table 108. Novartis Latest Developments
Table 109. Daiichi Sankyo Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 110. Daiichi Sankyo Alzheimer's Disease Drug Product Offered
Table 111. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Daiichi Sankyo Main Business
Table 113. Daiichi Sankyo Latest Developments
Table 114. Merz Pharma Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 115. Merz Pharma Alzheimer's Disease Drug Product Offered
Table 116. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Merz Pharma Main Business
Table 118. Merz Pharma Latest Developments
Table 119. Pfizer Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 120. Pfizer Alzheimer's Disease Drug Product Offered
Table 121. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Pfizer Main Business
Table 123. Pfizer Latest Developments
Table 124. Johnson & Johnson Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 125. Johnson & Johnson Alzheimer's Disease Drug Product Offered
Table 126. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Johnson & Johnson Main Business
Table 128. Johnson & Johnson Latest Developments
Table 129. Lundbeck Basic Information, Alzheimer's Disease Drug Manufacturing Base, Sales Area and Its Competitors
Table 130. Lundbeck Alzheimer's Disease Drug Product Offered
Table 131. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Lundbeck Main Business
Table 133. Lundbeck Latest Developments
List of Figures
Figure 1. Picture of Alzheimer's Disease Drug
Figure 2. Alzheimer's Disease Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alzheimer's Disease Drug Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Alzheimer's Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alzheimer's Disease Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Donepezil
Figure 10. Product Picture of Memantine
Figure 11. Product Picture of Rivastigmine
Figure 12. Product Picture of Others
Figure 13. Global Alzheimer's Disease Drug Sales Market Share by Type in 2021
Figure 14. Global Alzheimer's Disease Drug Revenue Market Share by Type (2017-2022)
Figure 15. Alzheimer's Disease Drug Consumed in Early to Moderate Stages
Figure 16. Global Alzheimer's Disease Drug Market: Early to Moderate Stages (2017-2022) & (M Units)
Figure 17. Alzheimer's Disease Drug Consumed in Moderate to Severe Stages
Figure 18. Global Alzheimer's Disease Drug Market: Moderate to Severe Stages (2017-2022) & (M Units)
Figure 19. Global Alzheimer's Disease Drug Sales Market Share by Application (2017-2022)
Figure 20. Global Alzheimer's Disease Drug Revenue Market Share by Application in 2021
Figure 21. Alzheimer's Disease Drug Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Alzheimer's Disease Drug Revenue Market Share by Company in 2021
Figure 23. Global Alzheimer's Disease Drug Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Alzheimer's Disease Drug Revenue Market Share by Geographic Region in 2021
Figure 25. Global Alzheimer's Disease Drug Sales Market Share by Region (2017-2022)
Figure 26. Global Alzheimer's Disease Drug Revenue Market Share by Country/Region in 2021
Figure 27. Americas Alzheimer's Disease Drug Sales 2017-2022 (M Units)
Figure 28. Americas Alzheimer's Disease Drug Revenue 2017-2022 ($ Millions)
Figure 29. APAC Alzheimer's Disease Drug Sales 2017-2022 (M Units)
Figure 30. APAC Alzheimer's Disease Drug Revenue 2017-2022 ($ Millions)
Figure 31. Europe Alzheimer's Disease Drug Sales 2017-2022 (M Units)
Figure 32. Europe Alzheimer's Disease Drug Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Alzheimer's Disease Drug Sales 2017-2022 (M Units)
Figure 34. Middle East & Africa Alzheimer's Disease Drug Revenue 2017-2022 ($ Millions)
Figure 35. Americas Alzheimer's Disease Drug Sales Market Share by Country in 2021
Figure 36. Americas Alzheimer's Disease Drug Revenue Market Share by Country in 2021
Figure 37. United States Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Alzheimer's Disease Drug Sales Market Share by Region in 2021
Figure 42. APAC Alzheimer's Disease Drug Revenue Market Share by Regions in 2021
Figure 43. China Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Alzheimer's Disease Drug Sales Market Share by Country in 2021
Figure 50. Europe Alzheimer's Disease Drug Revenue Market Share by Country in 2021
Figure 51. Germany Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Alzheimer's Disease Drug Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Alzheimer's Disease Drug Revenue Market Share by Country in 2021
Figure 58. Egypt Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Alzheimer's Disease Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Alzheimer's Disease Drug in 2021
Figure 64. Manufacturing Process Analysis of Alzheimer's Disease Drug
Figure 65. Industry Chain Structure of Alzheimer's Disease Drug
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
